Bone consists of separate inner endosteal and outer periosteal compartments, each with distinct contributions to bone physiology and each maintaining separate pools of cells owing to physical separation by the bone cortex. The skeletal stem cell that gives rise to endosteal osteoblasts has been extensively studied; however, the identity of periosteal stem cells remains unclear 1-5 . Here we identify a periosteal stem cell (PSC) that is present in the long bones and calvarium of mice, displays clonal multipotency and self-renewal, and sits at the apex of a differentiation hierarchy.
). Therefore, within the mesenchymal compartment, Ctsk cre selectively labels the periosteum 7 (Fig. 1c ).
This labelling suggested that a periosteal stem cell exists within the mesenchymal CTSK-mGFP + population (Fig. 1a-c) . To test this, we fractionated CTSK-mGFP mesenchymal cells using multi-colour flow cytometry ( Fig. 1f -j, Extended Data Fig. 1i ). We observed three populations among CTSK-mGFP cells lacking THY1.2 and 6C3 8 , all of which were CD49f low CD51 low : CD200 + CD105 − periosteal mesenchymal stem cells (PSCs), CD200 − CD105 − periosteal progenitor 1 (PP1) cells, and CD105 + CD200 variable periosteal progenitor 2 (PP2) cells (Fig. 1f, g, . Immunostaining confirmed the presence of CD200 + CTSK-mGFP cells in the periosteum and also identified subsets of CTSK-mGFP cells expressing gremlin 1 5 and nestin 1 (Fig. 1e , Extended Data Fig. 1b, e, k) . Consistent with the restriction of haematopoiesis to the endosteal compartment, CTSK-mGFP + status, and expression of LEPR, CD146 and CD140α-markers that are present in mesenchymal cells and have the ability to support haematopoiesis 2, 3, 9, 10 -are mutually exclusive ( Fig. 1h -l, Extended Data Fig. 2e-g) . During embryonic development, periosteal CD200 + CTSK-mGFP cells consistent with PSCs were first observed at E14.5, concurrent with the onset of skeletal mineralization, and were distinct from CD200 + cells present within the chondroepiphysis (Extended Data Fig. 1a-e ).
PSCs display the stem cell properties of clonal multipotency, selfrenewal and the ability to give rise to the entire range of CTSK-mGFP cells. Serial mesensphere formation is an in vitro proxy for self-renewal 1 , and only PSCs possessed the capacity to form tertiary mesenspheres, retaining CD200 through this process ( Fig. 2a-c) . To determine which periosteal population sits at the apex of the CTSK-mGFP differentiation hierarchy, cell populations isolated by fluorescence-activated cell sorting (FACS) were cultured for 15 days, and subsequently reanalysed by flow cytometry; these PSCs differentiated into PP1 and PP2 cells in addition to THY1.2 + and 6C3 + cells (Fig. 2d ). By contrast, PP1s or PP2s did not produce PSCs in culture (Extended Data Fig. 2i ). Additionally, PSCs demonstrated in vitro clonal multipotency for differentiation into mature osteoblasts and adipocytes ( Fig. 2e) . Similarly, a clonogenic periosteal population can be identified by pulse labelling in vivo (Extended Data Fig. 2h ). PSCs also possessed the capacity to differentiate into chondrocytes ( Fig. 2e ). In summary, PSCs are the most stem-like of the CTSK-mGFP populations in vitro.
In contrast to other skeletal mesenchymal stem cells (MSCs) that mediate endochondral ossification, PSCs form bone in vivo via an intramembranous pathway. We transplanted PSCs and non-CTSK (Lin − ) MSCs under the kidney capsule of wild-type secondary recipient mice ( Fig. 2f, g) . Both non-CTSK MSCs and PSCs mediated de novo generation of bone organoids (Fig. 2h) . Consistent with the physiologic restriction of marrow recruitment to the endosteal compartment, Letter reSeArCH non-CTSK MSCs underwent endochondral ossification with cartilage differentiation and recruitment of haematopoietic elements, whereas PSCs mediated intramembranous bone formation without haematopoietic recruitment or cartilage formation . Otherwise, non-CTSK MSCs displayed similar performance to PSCs in bone organoid, clonal multipotency and mesensphere assays . No interconversion between non-CTSK MSCs and PSCs was observed after transplantation (Extended Data Fig. 3i-k) . Therefore, bone contains discrete stem cell populations with differing functional specializations 1, 2, 4, 5, 12 , including a PSC population specialized for periosteal physiology.
Additionally, PSCs sit at the apex of a differentiation hierarchy in vivo and are capable of self-renewal during serial transplantation assays 1, 9 . CTSK-mGFP PSCs were transplanted into the mammary fat pad of female Rosa26 mT/mG mice and analysed over two successive rounds of transplantation ( Fig. 2j ). After the first round of transplantation, PSCs both self-renewed and gave rise to the entire spectrum of CTSK-mGFP cells observed in native periosteum (Fig. 2k, top panels) . Similar results were observed in a kidney capsule system (Extended Data Fig. 4a ). PSCs from secondary hosts were re-isolated and transplanted into tertiary hosts where they again displayed intact self-renewal and differentiation capacity (Fig. 2k, bottom panels) . By contrast, CTSK-mGFP + PP1 or PP2 cells did not revert to PSCs after transplantation and were unable to maintain THY1.2 − , 6C3 − progenitor cells (Extended Data Figs. 3l-n, 4b, c). Therefore, PSCs retain both self-renewal and differentiation capacity through successive rounds of transplantation, Left, mGFP (green) signal in femur/tibia of Ctsk cre ;Rosa26 mT/mG mice at postnatal day 10 (P10). Scale bar, 500 µm. Right, enlarged view of dotted white box in main panel. Arrows indicate the CTSK-mGFP signal in the periosteum. b, Endosteal CTSK-mGFP cells express the osteoclast marker TRAP (magenta). Scale bar, 20 µm. c, Representative FACS analysis of distribution of CTSK-mGFP cells in the endosteal digest, periosteum and total bone digests. ****P = 1.69 × 10 −5 , two-tailed Student's t-test; data are mean ± s.d.; n = 4 independent experiments. d, e, A subset of CTSK-mGFP (green) periosteal cells in the femur expresses type 1 collagen (d; magenta, orange arrow; bottom panel shows enlarged view of outlined area), and a subset expresses CD200 (e; magenta; yellow arrows; panels on the right show enlarged views of outlined areas). Scale bar, 25 µm (d, top), 200 µm (e, top) . An enlarged view of e is presented in Extended Data Fig. 1h . f, Flow cytometry of cells from long bone digests from P7 mice to identify periosteal stem cells (PSC) and progenitor cells (PP1, PP2). Colour-coded boxes (yellow, red, green) indicate parent/daughter gates. g, Percentage of PSC, PP1 and PP2 populations over time in long bone digests. PP1: **P = 0.0063 (day 15), ****P = 0.0001 (day 32). PP2: **P = 0.0022 (day 15), ***P = 0.0001 (day 32). One-way ANOVA, Sidak's multiple comparison test. Data are mean ± s.d.; n = 5 (days 7 and 15), n = 3 (day 32); representative of 3 independent experiments. h-j, Flow cytometry for LEPR (h), CD146 (i) and CD140α (j) versus CTSK-mGFP in long bones. k, l, There are significantly fewer CD146 + (k; ****P = 0.0000029) and CD140α + (l; **P = 0.0014) cells among CTSK-mGFP cells than among non-CTSK-mGFP cells. Two-tailed Student's t-test. Data are mean ± s.d.; 3 independent experiments. Images are representative of 5 (a, b) or 3 (d, e) independent experiments. Plots are representative of n = 20 (f) or n = 10 (h-j) independent experiments. Letter reSeArCH indicating that they are at the apex of the CTSK-mGFP differentiation hierarchy.
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We further examined the specialization of PSCs for intramembranous bone formation at the calvarium, a well-known site of intramembranous bone formation. Consistent with observations that calvarial sutures contain progenitors that migrate to calvarial periosteum as they mature 13, 14 , cells with a PSC immunophenotype exist predominantly in the sutures (Fig. 3a , c, d, Extended Data Fig. 4d, e ). By contrast, CTSK-mGFP + PP1 and PP2 cells, as well as THY1.2 + CD146 + SCA1 + cells, were predominantly present in the calvarial periosteum outside of the sutures ( Fig. 3b-d , Extended Data Fig. 4f -j). Calvarial PSCs are functionally equivalent to long bone PSCs, being at the apex of their differentiation hierarchy during in vitro and in vivo assays, and possessing similar gene expression, the capacity to form tertiary mesenspheres and bone organoids, and clonal multipotency (Extended Data Fig. 5 ). The few non-CTSK MSCs in the calvarium displayed low in vitro bone formation capacity (Extended Data Fig. 5d-f ). Therefore, PSCs are present in the calvarial sutures, suggesting that PSCs orchestrate intramembranous ossification at multiple anatomic sites. 
Transcriptional analysis shows that PSCs from mouse femur are broadly different from both their PP1 and PP2 derivatives and other skeletal MSCs (Fig. 3e , Extended Data Fig. 6a , g). Both PSCs and non-CTSK-mGFP MSCs share expression of genes associated with mesenchymal stem or progenitor cells, including Runx2 and Sox9, alongside stemness-associated genes such as Myc 15 and Klf4 16 , whereas PSCs expressed higher levels of Nanog and Wnt5a 17 (Fig. 3f ). Notably, PSCs displayed increased per-cell bone formation capacity compared to PP1/PP2 cells after kidney capsule transplantation (Extended Data Fig. 6b-d ). Calvarial PSCs also displayed similar patterns of gene expression as those observed in femoral PSCs (Extended Data Fig. 5g ). In parallel, to empirically determine the populations present within the pool of femoral CTSK-mGFP + Lin − cells, we performed single-cell RNA sequencing (RNA-seq) analysis using CEL-Seq2 18 . Mesenchymal CTSK-mGFP + cells clustered into four groups: a group expressing progenitor/stem cell markers 19 such as Sox9 and Col2a1, a group expressing osteoblast markers such as Bglap and Alpl, a group expressing Ly6a (also known as Sca1) and a small group with high expression of Acta2 (Fig. 3g , h, Extended Data Fig. 6e , f). Unsupervised construction of an inferred differentiation trajectory using Monocle 20 empirically identified a population corresponding to the PSCs obtained by FACS ( Fig. 3i-j ). Transcriptional markers of mesenchymal stem or progenitor cells were expressed in the early part of this differentiation trajectory containing PSCs (Fig. 3k, l) . Therefore, combined index sorting and single-cell RNA-seq independently identify a discrete PSC population similar to that identified by FACS, and PSCs display transcriptional signatures of mesenchymal stem cells and are distinct from other CTSK-mGFP cell populations.
To evaluate the physiologic importance of PSC-derived osteoblasts to bone formation, we blocked the ability of PSCs to give rise to osteoblasts by conditionally deleting the osterix gene (Osx, also known as Sp7), which encodes a transcription factor essential for osteoblast differentiation 21, 22 , using Ctsk cre . Osx fl/fl ;Ctsk cre mice displayed hypomineralization of the calvarium, uneven periosteal surfaces, and extensive linear intra-cortical pores that gave a characteristic appearance of a double cortex ( Fig. 4a-d , Extended Data Fig. 7a ). Endosteal trabecular bone mass was not substantially altered (Extended Data Fig. 7d ). Otherwise, bone morphology and growth plate architecture were intact in Osx fl/fl ;Ctsk cre mice aside from a slight reduction in long bone length (Extended Data Fig. 7b , c). Bone formation rates were significantly reduced in the periosteum of Osx fl/fl ;Ctsk cre mice, with a compensatory increase in endosteal bone formation ( Fig. 4e , Extended Data Fig. 7e ). TRAP staining showed no changes in osteoclast numbers 23 (Extended Data Fig. 7f , g). Consistent with histomorphometry results, the in vivo and in vitro osteogenic potential of both long bone and calvarial PSCs but not endosteal MSCs was reduced in Osx fl/fl ;Ctsk cre mice (Extended Data Fig. 7h-j) . Therefore, PSC-derived osteoblasts are necessary for periosteal bone formation and the establishment of normal cortical architecture.
Consistent with observations that the periosteum is necessary for fracture repair 24, 25 , PSC-derived osteoblasts expand in response to injury and are necessary for fracture healing. PSCs exhibited a greater expansion than non-CTSK MSCs in femurs 8 days after fracture (Fig. 4f, g, 8, . PSCs isolated from the fracture site displayed enhanced osteoblast differentiation capacity on a per-cell basis in vitro ( Fig. 4i ). Therefore, fracture markedly increases both the numbers and the osteoblast differentiation capacity of PSCs.
It is a longstanding apparent contradiction that periosteum undergoes intramembranous bone formation at baseline while also being necessary for endochondral fracture repair. We examined whether PSCs could explain this apparent contradiction by switching from a baseline intramembranous bone formation capacity to acquire endochondral bone formation capacity after fracture. No CTSK-mGFP labelling of chondrocytes is observed at baseline; however, CTSK-mGFP cells contributed approximately half of the chondrocytes present in the fracture callus (Extended Data Figs. 8a, 9d, e ). PSCs isolated from the fracture callus mediated endochondral ossification after transplantation into the kidney capsule ( Fig. 4h , j, Extended Data Fig. 9f, g) . Therefore, whereas there is a clear distinction between intramembranous-competent PSCs and endochondral-competent MSCs at baseline, injury can introduce plasticity or interconversion between these cell types. This offers an explanation for how the periosteum can contribute to the endochondral process of fracture repair despite being specialized for intramembranous formation at baseline.
Next, we investigated the functional contribution of PSC-derived osteoblasts to fracture healing in Osx fl/fl ;Ctsk cre mice, which displayed markedly impaired fracture healing with increased rates of fracture non-union and a decrease in the total fracture callus bone volume ( Fig. 4k-n) . Histologic analysis of the fracture callus was consistent with defects in mineralization, showing decreased bone and increased cartilage in the callus (Extended Data Fig. 10a-g) .
To establish whether a population analogous to PSCs exists in humans, human periosteal tissue from femur was sectioned and stained, showing that cells express cathepsin K and CD200 (Fig. 4o) . Similarly, flow cytometry revealed the presence of a population (Lin − CD90 − CD200 + CD105 − ; hereafter h-PSCs) in human periosteum bearing an immunophenotype similar to that of mouse PSCs (Fig. 4p , Extended Data Fig. 10h -k). These human PSCs were multipotent as they underwent osteogenic, adipogenic and chondrogenic differentiation in vitro ( Fig. 4q ). When transplanted into the kidney capsule of immunocompromised mice, h-PSCs, h-PP1 and h-PP2 cells all mediated intramembranous bone formation ( Fig. 4r , Extended Data Fig. 10l ). Therefore, human periosteum contains a population analogous to PSCs.
In this study, we identified a stem cell that serves as a physiologic precursor of periosteal osteoblasts, and has a critical role in both fracture healing and modelling of the bone cortex. As the bone cortex is essential for the biomechanical resistance of bone to fracture [26] [27] [28] [29] , isolation of PSCs is likely to facilitate both the development of drugs that increase cortical bone thickness as well as cellular therapy for skeletal injury 30 . Moreover, the existence of a discrete periosteal stem cell demonstrates that bone consists of multiple distinct pools of stem cell progenitors, which in turn enables the functional specialization of each of these stem cell types and their derivatives. In this regard, PSCs are specialized for intramembranous bone formation at baseline, providing a cellular basis for long-observed differences between intramembranous and endochondral bone formation. Lastly, the interconversion between PSCs and endochondral-competent populations suggests that such interconversions may occur more broadly and contribute to the cellular basis of skeletal pathology.

MEthodS
Animals. Cathepsin K-Cre (Ctsk cre ) mice 31 were a gift from S. Kato (University of Tokyo). Floxed osterix (Osx fl/fl ) mice 22 were a gift from B. de Crombrugghe (University of Texas M. S. Anderson Cancer Center). R26R confetti (Stock 017492), Actb creER (Stock 004682), NOD/SCID/IL2Rγ (NSG, Stock 005557) and Rosa26 mT/mG mice (Stock 007676) 32 were purchased from Jackson Laboratories. All mice were maintained on a C57BL6/J background throughout the study. All animals were maintained in accordance with the NIH Guide for the Care and Use of Laboratory Animals and were handled according to protocols approved by the Weill Cornell Medical College subcommittee on animal care (IACUC). For all cellular transplantation experiments, the recipient animals for each specific cell population transferred were randomized after selecting a group of gender-appropriate mice. Generally, sample sizes were calculated on the assumption that a 30% difference in the parameters measured would be considered biologically significant with an estimate of sigma of 10-20% of the expected mean. Alpha and Beta were set to the standard values of 0.05 and 0.8, respectively. Blinding. µCT analysis, mesensphere calculation, histomorphometry, immunohistochemistry were performed by individuals that were blinded to the identity of the groups. Cell line. Validation for single-cell sorting was initially done with RAW264.7 cells from ATCC (ATCC TIB-71), a commercially available mouse macrophage cell line. These cells were not independently authenticated since they were obtained directly from ATCC and were only used to validate single-cell sorting capabilities before experimentation. Cells were tested for mycoplasma using the PlasmoTest Mycoplasma Detection Kit from InvivoGen (rep-pt2) and PCR analysis. All cells were confirmed to be free of mycoplasma. Tamoxifen injection. Actb creER activity was induced at postnatal day 3. Tamoxifen (100 mg/kg) (Sigma) was prepared in corn oil and injected intraperitoneally into nursing females for 3 consecutive days. Nursing females in control groups were simultaneously injected with corn oil only. The resulting litters were killed 14 days after induction and femurs were fixed for 4 h with 4% paraformaldehyde (PFA) and processed for imaging as described below. Human samples. This project was approved by the IRB committee of Memorial Sloan Kettering Cancer Center (MSKCC) (IRB No. 97-094). HIPAA authorization was included in the IRB protocol and all ethical guidelines conform to the 2008 Helsinki declaration. Patient consent was obtained and all identifying patient information was scrubbed at the time of sample procurement. Isolation of mesenchymal cells. Skeletal tissue from postnatal day 7, 15 or 32 mice was subjected to both mechanical and enzymatic digestion. The harvested tissue was minced using razor blades and digested for up to 1 h with Collagenase P (1 mg/ml; Roche, cat. 11213857001) and Dispase II (2 mg/ml; Roche, cat. 04942078001) digestion buffer at 37 °C with agitation. Medium containing 2% serum was added to the digest and the tubes were centrifuged to pellet cells. The supernatant was removed, and the pellet was resuspended in DNase I (2 units/ml) solution and briefly incubated for 5 min at 37 °C. Medium was added to the tube and the digested tissue was resuspended thoroughly by pipetting and then filtered through 70-µm nylon mesh. Tubes were centrifuged and the resulting cell pellet was subjected to FACS. Microdissection of mouse periosteum, calvarial suture and calvarial periosteum was performed under a dissecting microscope and the resulting tissue samples were subjected to the same digestion protocol. For human samples, tissue was treated with Pronase (1 mg/ml; Roche, cat. 10165921001) for 20 min at 37 °C under agitation and spun down at 1500 r.p.m. for 10 min before collagenase treatment as above. Fluorescence assisted cell sorting (FACS). Cells were washed twice with ice-cold FACS buffer (2% FBS + 1 mM EDTA in PBS), incubated with blocking buffer (1:100 dilution; BD bioscience 553142 for mouse and 564765 for human) for 15 min at 4 °C. Primary antibody dilutions were prepared in brilliant stain buffer (BD bioscience 563794). Cells were incubated in the dark for 1 h on ice with primary antibody solution, washed 2-3 times with FACS buffer, and incubated with secondary antibody solution for 20 min. Cells were then washed several times and resuspended in FACS buffer with DAPI (4′,6-diamidino-2-phenylindole; 1 µg/ml; Invitrogen D1306). FACS was performed using a Becton Dickinson Aria II equipped with 5 lasers (BD bioscience). Beads (eBioscience 01-1111) were used to set initial compensation. Fluorescence minus one (FMO) controls were used for additional compensation and to assess background levels for each stain. Gates were drawn as determined by internal FMO controls to separate positive and negative populations for each cell surface marker. Typically, 1-2 million events were recorded for each FACS analysis, and the data was analysed using FlowJo (v.10.1). Calculations were made in Excel and bar graphs were generated in GraphPad Prism. To better depict the FACS gating strategy, we have made changes throughout our figures, using colour-coded boxes to illustrate parent/daughter gates. Additionally Extended Data Fig. 2d has been provided to show the full details of the gating strategies used. FACS antibodies. Antibodies for FACS of human samples included CD235a (clone HIR2, eBioscience), CD31 (cloneWM-59, eBioscience), CD45 (BD Bioscience), CD90 (clone 5E10, BD Bioscience), CD140α (clone aR1, BD Bioscience), CD105 (clone 266, BD Bioscience), CD200 (clone MRC OX-104, BD Bioscience), CD146 (clone P1H12, BD Bioscience), CD140α (clone αR1, BD Bioscience), CD49f (clone GoH3, BD Bioscience), CD51 (clone NKI-M9, Biolegend) and CD295 (clone 52263, BD Bioscience). Antibodies for FACS of mouse samples included CD45 (clone 30-F11, BD Bioscience), CD31 (MEC13.3, BD Bioscience), Ter119 (clone Ter119, BD Bioscience), CD90.2 (clone 53-2.1, BD Bioscience), BP-1 (clone 6C3, eBioscience), CD200 (clone OX-90, BD Bioscience), CD105 (clone MJ7/18, Biolegend), CD146 (clone ME-9F1, BD Bioscience), CD140α (clone APA5, Biolegend), CD49f (clone GoH3, BD Bioscience), CD51 (clone RMV-7, BD Bioscience), Ly6A/E (clone D7, BD bioscience), leptinR (R&D systems), CD61 (clone 2C9.G2, BD Bioscience), streptavidin eFluor 710 (eBioscence) and streptavidin BUV737 (BD Bioscience). Cell culture. Sorted cells were cultured both under hypoxic (2% O 2 , 10% CO 2 , 88% N 2 ) and non-hypoxic conditions (20% O 2 ). In vitro differentiation of FACSisolated populations was conducted under hypoxic conditions (Fig. 2d , Extended Data Figs. 2i, 3h , 5k-m). Clonal multipotency of sorted cell populations was evaluated under non-hypoxic conditions ( Figs. 2e, 4q, Extended Data Figs. 3d, 5c ). Mesensphere formation capacity was evaluated under non-hypoxic conditions ( Fig. 2a, Extended Data Figs. 3f, 5a ).
Mouse primary cells were grown in complete mesencult medium (basal medium, 05501, Stem Cell Technologies) with stimulatory supplements (05502, 05500, Stem Cell Technologies). After initial cell plating, cells were left undisturbed and allowed to grow at 37 °C under humidified conditions for a week. Half of the medium was replaced every 7 days. Cells were passaged once they were 60-70% confluent with Stem Pro Accutase solution (Gibco, A11105-01). Sorted human cells were cultured under conditions similar to those described above using a commercial medium preparation (basal medium, 05401, Stem Cell Technologies) with stimulatory supplements (05402, Stem Cell Technologies). Mesensphere assays. For mesensphere assays, FACS-isolated single cells were plated at a density of 100 cells per cm 2 and allowed to grow in ultra-low adherence culture dishes (Stem Cell Technologies, 27145). Plates were incubated at 37 °C with 5% CO 2 and left undisturbed for a week. Half of the medium was replaced every 7 days. Mesenspheres were dissociated into single cells using Accutase solution (Gibco, A11105-01) and were subsequently re-plated to generate secondary and tertiary mesenspheres. Clonal differentiation assay. The differentiation potential of 10 colonies derived from single FACS-isolated PSCs was examined ( Fig. 2e ). In brief, single FACSsorted cells were plated at a density of 100 cells per 10-cm dish and allowed to form individual colonies. Initial dispersion of the plated cells as single cells was confirmed by light microscopy. Each of the selected colonies was extracted using a cloning cylinder. The extracted cells were regrown for 3-4 days in 12-well plates and then allowed to differentiate under both osteogenic and adipogenic conditions as described below. A similar approach was used to analyse clonal differentiation of FACS-sorted calvarial PSCs (Extended Data Fig. 5c ). Osteogenic differentiation and alizarin red staining. Sorted cells were expanded and then allowed to differentiate using osteogenic differentiation medium (Stem Pro Osteogenesis Differentiation kit, A10072-01) for 19-28 days. Medium was changed every 2 days. At the end of this period, cells were washed with cold PBS and fixed with 70% ethanol for 15 min on ice. Cells were washed with distilled water and stained with alizarin red solution for 2-3 min. Cells were then washed thoroughly with water and air dried before microscopic visualization. Adipogenic differentiation and oil red O staining. Adipogenic differentiation was similarly conducted with sorted cells as described above. In brief, cells were allowed to differentiate in adipogenic differentiation medium (Stem Pro Adipogenesis Differentiation kit, A10070-01). Fresh medium was added every 2-3 days for a total of 14-20 days. Medium was removed, and cells were washed with PBS and fixed with 4% PFA for 30 min at room temperature. Cells were rinsed again with PBS and stained for 30 min with oil red O working solution (3:2 dilution with water). Cells were then observed under a light microscope after 4-5 washes with PBS. Chondrogenic differentiation and alcian blue staining. Micromass cultures were generated by seeding 1 × 10 5 cells in 5-10 µl of basal medium. Cells were allowed to adhere to a glass slide for 2 h under highly humidified conditions at 37 °C. Chondrogenic differentiation medium (Stem Pro Chondrogenesis Differentiation kit, A10071-01) was slowly added and cells were incubated at 37 °C with 5% CO 2 .
Cultures were re-fed every 2-3 days and allowed to differentiate for a minimum of 14 days. At the end point of this study, medium was removed, and cultures were washed with PBS and fixed with 4% PFA for 30 min. Cultures were stained for 30 min with 1% alcian blue solution, washed three times with 0.1 N HCl and then with PBS.
Separately, pellet culture was conducted with 250 × 10 3 cells seeded in 15-ml polypropylene tubes. The pellet was cultured in chondrogenic differentiation medium, which was changed every 2-3 days for a period of 2 weeks. The pellet was harvested, fixed with 4% PFA and embedded in OCT with 15% sucrose solution. Sections, 10 µm in thickness, were cut and alcian blue staining was performed as described. Surgical procedures. All surgical procedures were performed under isoflurane (1-4%) anaesthesia. Surgical sites were sterilized using a betadine/iodide/isopropanol prep after hair removal using a clipper with a no. 40 blade and a depilatory cream (Nair). After surgery, the visceral lining or muscle was sutured with absorbable Ethicon vicryl sutures (VWR, 95057-014) before closing the skin with wound clips that were removed 2 weeks post-operatively. Animals received intraperitoneal buprenex (0.5 mg/kg) and oral meloxicam (2.0 mg/kg) as analgesia before surgery and for every 24 h post-surgery for 3 days. All surgical procedures are approved by the institutional animal care and use committee at Weill Cornell Medical College. Kidney capsule transplantation model. In brief, 8-10-week-old male mice were anaesthesized and shaved on the left flank and abdomen before sterilization of the surgical site. The kidney was externalized through a 1-cm incision and a 2-mm pocket was made in the renal capsule. A 5-µl Matrigel plug (Corning, 356231) containing 8,000-10,000 cells was implanted underneath the capsule and the hole was sealed using a cauterizer before replacing the kidney back into the body cavity. Recipients for these experiments were syngenic with donors. Moreover, to avoid potential immunogenicity of GFP itself, all transplantation studies of CTSK-mGFP + cells were conducted in mTmG hosts that have baseline immunologic tolerance to GFP variants. Animals were euthanized by CO 2 after 6 weeks. After death, kidneys were fixed with 4% PFA for 5 h and bone formation was detected by µCT. Samples were subjected to infiltration, embedding and sectioning as described below. Haematoxylin and eosin and Von Kossa staining were performed following previously described protocols 33 . Standard safranin O stain and alizarin red staining was performed to detect cartilage and bone components.
Altogether, over 30 individual mouse transplantation procedures were conducted across 5 separate days of experimentation to study the intramembranous versus endochondral differentiation preferences of PSCs versus non-CTSK MSCs. Mammary fat pad transplantation model. To facilitate distinguishing host cells from CTSK-mGFP + transplanted cells, 3-4-week-old female mTmG mice were used, where all host cells were mTomato + . These mice were anaesthesized and their lower abdomen was shaved before sterilization of the surgical site. A 1-1.5-cm longitudinal incision was made along the midline of the body wall below the sternum and just above the pelvic region. A second 0.5-cm cut was made from the bottom of the midline incision towards the hip of the right hind limb. The skin was carefully pulled away from the peritoneum to expose the inguinal mammary gland. A 2-mm pocket was created in the mammary fat pad just below the lymph node and a 5-µl Matrigel plug with the desired number of cells was implanted into the pocket. The pocket was sealed by clamping the edges of the cut fat pad together with a toothed forcep. Wound clips were used to close the skin incisions. Animals were euthanized by CO 2 at 2.5 weeks post-surgery, and the mammary fat pad was extracted, minced with razor blades and digested at 37 °C in digestion buffer (Collagenase P (1 mg/ml) and Dispase II (2 mg/ml) in 2% serum medium) for 30-45 min. Medium was added and the tubes were spun for 10 min at 1,500 r.p.m. The supernatant was carefully removed and DNase I solution was added for 5 min without disturbing the pellet. The reaction was terminated by diluting the digestion solution with medium. Tubes were again spun for 10 min and the resulting pellet was prepared for FACS analysis. Femur fracture model. In brief, after anaesthesia, an incision was made above the right anterolateral femur after sterilization of the surgical site. The femur and patella were then exposed and a 27-gauge syringe needle was inserted parallel with the long axis of the femur through the patellar groove into the marrow cavity. The needle was then removed and a single cut in the mid-diaphysis of the femur was made using a Dremel saw with a diamond thin cutting wheel (VWR, 100230-724) . A blunt 25-gauge needle was then reinserted into the marrow space through the hole made in the femur to stabilize the fracture. This needle was then trimmed so it would not project into stifle joint space. Muscle was then placed over the injury site and stitched with absorbable sutures before closing the skin with wound clips. We performed femur fracture in 6-week-old Ctsk cre ;mTmG mice ( Fig. 4f-h) and 4-week-old Osx fl/fl ;Ctsk cre mice (Fig. 4k ). Mice were killed by CO 2 asphyxiation after 3 weeks. Sample preparation for cryo-sectioning. Freshly extracted mouse samples were fixed with 4% PFA for 4 h at 4 °C. Samples were washed with PBS and decalcified with 0.5 M EDTA for 1-5 days depending on the age of the sample. Samples were incubated with infiltration solution (20% sucrose + 2% polyvinylpyrrolidone in PBS) with rocking until they sank to the bottom of the tube. Embedding was performed with OCT + 15% sucrose and samples were preserved at −80 °C. Sections, 10-20 µm in thickness, were cut using a Leica cryostat. Immunohistochemistry. Frozen samples were thawed at room temperature and rehydrated with PBS, permeabilized with PBS + 0.3% Triton X-100 for 15 min, and blocked for 1 h with 5% donkey serum in PBS (blocking buffer). Dilutions of primary antibodies were freshly prepared in blocking buffer. Samples were incubated overnight with primary antibodies at 4 °C, then washed three times with PBS. Secondary antibodies (1:2,000 dilution) were added to the sample for 1-2 h, followed by washing three times with PBS. DAPI (300 nM) was added for 5-10 min and the samples were mounted with antifade mounting solution (Life technologies, P36970). Imaging was performed with a Zeiss LSM 880 with Airyscan high-resolution-detector confocal microscope. For immunohistochemistry of mesenspheres, mesenspheres were extracted and allowed to adhere on glass chamber slides for 24 h. Spheres were fixed with 4% PFA for 15 min at room temperature, washed twice with PBS, permeabilized with PBS + 0.5% Triton X-100 for 10 min and blocked for 1-2 h with blocking buffer (PBS + 2% BSA + 10% horse serum + 0.5% Triton X-100). Primary antibody dilutions were prepared in blocking buffer, and added to the spheres followed by overnight incubation at 4 °C. Samples were washed three times with PBS and incubated with secondary antibody for 1 h and DAPI solution for 10 min. Samples were subsequently processed for imaging as described above. Primary antibodies for immunohistochemistry. Primary antibodies used were specific for collagen type I (Abcam, ab34710, 1:100 dilution), collagen type II (Millipore, MAB8887, 1:100 dilution), murine CD200 (Abcam, ab33734, 1:100 dilution), nestin (Abcam, ab11306, 1:200 dilution), gremlin 1 (Abcam, ab189267, 1:50 dilution), COMP (Abcam, ab74524, 1:50 dilution), Aggrecan (Abcam, ab3778, 1:100 dilution), THY1.2 (Invitrogen, 14-0902-82, 1:50 dilution), 6C3 (Invitrogen, 14-5891-82 1:50 dilution), CD105 (Abcam, ab107595, 1:100 dilution), Runx2 (Abcam, ab76956, 1:200 dilution), Alpl (Abcam, ab108337, 1:100 dilution), osteocalcin (Abcam, ab93876, 1:100 dilution), CD146 (Abcam, ab75769, 1:100 dilution), CD140α (Abcam, ab96569, 1:100 dilution), CD200 (Abcam, ab203887, 1:200 dilution), tartrate resistant acid phosphatase (TRAP) (Abcam, ab185716, 1:50 dilution), and cathepsin K (Abcam, ab19027, 1:200 dilution). Calcein labelling. Calcein stock solution (2.5 mg/ml) was freshly prepared in calcein buffer (ddH 2 O + 2% NaHCO 3 + 150 mM NaCl). Four-week-old Osx fl/ fl;Ctsk cre mice from the same litter were given subcutaneous calcein injection (10 mg/kg) followed by a second injection after 2 days. Mice were euthanized after 24 h, fixed overnight in 10% formalin solution and then stored in 70% ethanol. Non-decalcified femur sections were prepared for plastic embedding according to a previously published protocol 33 . Histomorphometry. Mice underwent dual calcein labelling, and undecalcified femur sections were prepared for analysis and stained for TRAP as previously described 33 . Dynamic histomorphometry parameters were measured using the Osteomeasure Analysis system (Osteometrics) and reported following standard nomenclature 34 . Mineral apposition rate (MAR; µm day −1 ), bone formation rate/ bone surface (BFR/BS; µm 3 mm −2 day −1 ), bone volume (BV; mm 3 ), bone volume/ total volume (BV/TV), osteoclast number/bone perimeter (No. Oc/B. Pm) were determined. μCT and paraffin embedding. µCT was conducted following the previously described parameters 35 on a Scanco Medical Micro-CT35 system at the Citigroup Biomedical Imaging Core. µCT operators and evaluators were blinded to the experimental groups under analysis. Human periosteal samples were fixed overnight with 4% PFA at 4 °C. Samples were decalcified with 0.5 M EDTA for 5-6 days and then subjected to paraffin embedding. The Translational Research Pathology Core at Weill Cornell performed paraffin embedding, sectioning and staining (haematoxylin and eosin, CD200 and cathepsin K stain for human samples) following a previously published protocol 35 . Bulk RNA-seq. Bulk RNA-seq was performed on sorted PSC, PP1, PP2, and non-CTSK MSC populations isolated from 6-day-old mouse femurs. cDNA libraries were generated using the Illumina TruSeq RNA Sample Preparation kit and sequenced on HiSeq4000 sequencer. Tophat2 was used to align raw sequencing reads to the mm10 mouse reference genome. Differential expression analysis was performed using DESeq2 package. The heat map was generated using heatmap.2 in the R gplots package, where the expression values were normalized per gene over all samples 36 . For each gene, the mean and standard deviation (s.d.) of expression over all samples was calculated, and the expression value underwent linear transformation using the formula (RPKM − mean)/s.d. For 16 bulk RNA samples, the average raw reads per sample was 46.2 million. Single-cell RNA-seq using CEL-Seq2. Validation for single-cell sorting was initially done with RAW264.7 cells using 384-well plates. Single-cell sorting was confirmed through observation of growth of a single colony from the sorted cells (Extended Data Fig. 6h ). We found that cells were sorted into wells at 93% efficiency and the doublets were detected in less than 2% of cases (Extended Data Fig. 6i ).
For the experiment, CTSK-mGFP + cells isolated from a 6-day-old mouse femur were sorted by FACS (Becton-Dickinson Influx) and plated into individual wells of a 384-well plate pre-loaded with unique barcoded reverse-transcription primers. After sorting, cells were snap-frozen on dry ice before being submitted to the New York Genome Center (NYGC) for cDNA synthesis and library preparation. cDNA synthesis was performed in individual wells using a template-switching mechanism followed by PCR amplification. All barcoded amplified cDNA was then pooled and run on a pico-green assay and fragment analyzer to evaluate sample concentration Letter reSeArCH and quality, respectively. Libraries were generated from 300 pg of pooled cDNA using the Nextera XT library preparation kit (Illumina). The library was then sequenced with custom sequencing primers across two lanes of a 25 bp × 75 bp rapid run (HiSeq 2500 instrument). Read 1 was composed of the cell barcode and unique molecular identifier (UMI), whereas read 2 was used to map the transcript to the mouse genome. After sequencing, the alignment and analysis was done using the NYGC re-tooled pipeline based on Drop-seq Core tools 37 (http://mccarrolllab. org/dropseq/ which provided basic quality control and expression analysis. The delivered data contained FASTQ, BAM files and an expression matrix. Seurat analysis. Seurat v.2.0.1 and R v.3.4.1 were used for analysis of single-cell RNA-seq data 38 . Cells expressing at least 200 but not more than 5,500 genes were retained for analysis. Genes expressed in less than 3 cells were not taken into consideration. A total of 658 single cells were analysed for the total number of UMIs per cell, percentage of mitochondrial gene expression, percentage of ribosomal gene expression, and cell cycle. Initial clustering analysis showed an even distribution of mitochondrial gene content across clusters, so this was not considered further (data not shown). Cell cycle analysis was performed using a previously published approach 39 . Regression was performed to remove effects associated with cell cycle state, the number of UMIs and ribosomal gene content. Clustering was performed using the first 12 principal components and clusters were visualized using t-SNE projection. Monocle analysis. Cell trajectory analysis was performed by using Monocle on CTSK-mGFP cells. Monocle v. 2.4.0 and R v.3.4 .0 were used to conduct analysis on the single-cell sequencing data. Monocle analysis [40] [41] [42] was performed using negbinomial.size function and the data was loaded using sparseMatrix. Quality control was performed by filtering low-quality cells including dead cells, empty wells in the plate and doublets. The mRNA threshold was defined and cells with mRNA content between 35,000 through 295,000 were analysed (Extended Data Fig. 6j ). The same CEL-Seq2 dataset as used above was loaded for analysis (Extended Data Fig. 6k ). Cell trajectory was obtained using genes selected by a principalcomponent-analysis-based method for cell ordering according to previously described methods [40] [41] [42] . Regression was performed to remove effects associated with cell cycle state and ribosomal gene content. A list of differentially expressed genes that change as a function of pseudotime was obtained using fullModelFormulaStr. Genes that were significant at 10% false discovery rate were selected. Heat maps to visualize pseudotime-dependent genes were generated by using a subset of the significant genes. Statistical analyses. All data are shown as the mean ± s.d. or mean ± s.e.m. as indicated. Where applicable, we first performed the Shapiro-Wilk normality test to check normality. For comparisons between two groups, a two-tailed, unpaired Student's t-test was used. If normality tests failed, Mann-Whitney U-tests were used. For comparisons of three or more groups, one-way ANOVA was used if normality tests passed, followed by Tukey's multiple comparison test for all pairs of groups. If normality tests failed, Kruskal-Wallis test was performed, followed by Dunn's multiple comparison test. GraphPad PRISM v.6.0a was used for statistical analysis. P < 0.05 was considered statistically significant. Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
RNA-seq and single-cell RNA-seq data have been deposited at the Gene Expression Omnibus under accession numbers GSE106237, linked to the subseries GSE106235 and GSE106236. Microscopy images are available from the corresponding author upon reasonable request. 32 (c) . Plots in a-c are representative of results from 10 independent experiments. d, Schematic representation of the strategy used for FACS analysis of periosteal PSC, PP1 and PP2 cell populations. e, FACS plot showing the distribution of CD146 (i) and CD140α (ii) expression in bone marrow stromal cells. f, FACS plots displaying the distribution of CD140α (i) and CD146 (ii) in mouse periosteum obtained through periosteal microdissection. Plots in e and f are representative of results from 5 independent experiments. g, Mouse bone marrow immunostained for CD146 (cyan) and CD140α (magenta). Scale bar, 100 µm. Representative images from 3 independent experiments. h, Clonogenic cells detected in the periosteum (top and middle, white arrows) and perichondrium region (bottom, white arrows) of mouse femur 2 weeks after induction of β-actin-Cre with tamoxifen. Enlarged views of outlined regions are shown. Scale bar, 50 µm. Representative images from 3 independent experiments. i, FACS plots showing in vitro differentiation for PP1 (left) and PP2 (right) cells after 15 days of culture. Representative FACS plots from 3 independent experiments. j, Alizarin red staining (red) of bone 5 weeks after transplantation of non-CTSK MSCs (left) and PSCs (right) into the kidney capsule. Representative images from 5 independent experiments. Scale bar, 50 µm. k, Relative gene expression for bone-(Runx2) and cartilage-specific genes (Col2a1, Comp, Chad) 5 weeks after transplantation of PSCs and non-CTSK MSCs. Non-CTSK MSC-derived cells display significantly higher expression of cartilage specific genes than PSCs. *P = 0.003 (Col2a1), *P = 0.002 (Comp), *P = 0.002 (Chad); twotailed Student's t-test. Data are mean ± s.d., n = 3. l, CTSK-mGFP + PSCs (green) were immunostained for Runx2 (magenta, top) and osteocalcin (magenta, middle and bottom) 3, 4 or 5 weeks after transplantation into the kidney capsule. Scale bar, 20 µm. Representative images from 3 independent experiments.
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Extended Data Fig. 3 | Functional characterization of non-CTSK MSCs, PSCs and their derivatives. a, Total numbers of PSCs and non-CTSK MSCs in mouse femurs at postnatal day 7, day 15 and day 32. Significant decreases in number of PSCs are observed at day 15 (**P = 0.006) and day 32 (**P = 0.009) compared to day 7. Significant decreases in non-CTSK MSCs are observed at day 15 (***P = 3.8 × 10 −5 ) and day 32 (***P = 0.0003) compared to day 7. Two-tailed Student's t-test. Data are mean ± s.d., n = 3 independent experiments; 5 animals per group for day 7, day 15; 3 animals per group for day 32. b, µCT images of the bone formed by non-CTSK MSCs (left) and PSCs (right) 5 weeks after transplantation. Representative images from 5 independent experiments. c, Quantification of bone volume when equal numbers of non-CTSK MSCs and PSCs were transplanted into secondary hosts. Data are mean ± s.e.m., n = 3 independent experiments; two-tailed Student's t-test. ns, not significant. d, Clonal non-CTSK MSC colonies were split for differentiation into osteoblasts (left, alizarin red staining) and adipocytes (middle, oil red O staining) (scale bar, 20 µm). Separately, chondrocyte differentiation potential was assayed (right, alcian blue staining; scale bar, 100 µm). Representative images from 4 independent experiments. e, Clonal differentiation capacity of 10 colonies isolated from PSCs and non-CTSK MSCs after subsequent culture under osteogenic (left) and adipogenic (right) differentiation conditions. All 10 colonies from each population were equally multipotent. Data are mean ± s.d., n = 3 independent experiments. f, Bright-field images of primary (left), secondary (middle) and tertiary mesenspheres (right) derived from non-CTSK MSCs. Tomato red (red) expression is shown in the insets. Scale bar, 20 µm. Representative images from 3 independent experiments. g, The percentage of PSCs and non-CTSK MSCs able to form mesenspheres. *P = 0.02, one-way ANOVA, Dunnett's multiple comparison test. Data are mean ± s.d., n = 3 independent experiments. h, FACS analysis of in vitro differentiation of non-CTSK MSCs after 15 days of culture. Red box indicates parent/daughter gate. i, FACS plots of non-CTSK MSC-derived cells after the first round of mammary fat pad transplantation. Colour-coded boxes (red and green) indicate parent/ daughter gates. FACS plots in h and i are representative of 3 independent experiments. j, FACS for CD140α (i) and CD146 (ii) in PSCs after transplantation into the mammary fat pad. k, FACS for expression of GFP (i),CD140α (ii), and CD146 (iii) in non-CTSK MSCs after mammary fat pad transplantation. l, PP1 cells were transplanted into the mammary fat pad of primary hosts for 2.5 weeks and then analysed by FACS (i-iii). Colour-coded boxes (green and magenta) indicate parent/daughter gates. m, n, PP2 cells were isolated by FACS and implanted into the mammary fat pad of primary recipients. PP2 derived cells in primary recipients were analysed by FACS (m, i-iv), and PP2 cells were re-isolated for transplantation into secondary recipients. PP2-derived cells in secondary recipients were analysed by FACS (n, i-iv). Colour-coded boxes (green, magenta and orange) indicate parent/daughter gates. Plots in j-n are representative of results from 3 independent experiments.
Extended Data Fig. 4 | Differentiation of PSCs, PP1 and PP2 cells when transplanted into kidney capsule of secondary hosts and FACS analysis of CTSK-mGFP calvarial cells. a, CTSK-mGFP + PSCs (green) were immunostained for THY1.2 (magenta, top), 6C3 (magenta, middle) and CD105 (magenta, bottom) three weeks after transplantation into the kidney capsule of primary recipients. b, CTSK-mGFP + PP1 cells (green) were immunostained for 6C3 (magenta, top) and CD105 (magenta, bottom) three weeks after transplantation into the kidney capsule. c, CTSK-mGFP + PP2 cells (green) were immunostained for THY1. 2 (magenta, top) , and CD105 (magenta, bottom) three weeks after transplantation into the kidney capsule. Scale bar, 50 µm. Images in a-c are representative of 3 independent experiments. Scale bar, 50 µm.
d, e, FACS analysis of PSCs, PP1s and PP2s at P15 in mouse calvarial suture (d) and calvarial periosteum (e). f, g, FACS for THY1.2 in CTSK-mGFP cells isolated from calvarial suture (f (i), g (i)) and calvarial periosteum (f (ii), g (ii)) at day 15 (left plots) and day 32 (right plots). Plots in d-g are representative of results from 3 independent experiments. h, CD146 and SCA1 expression in CTSK-mGFP cells from the suture (i, ii) and periosteum (iii, iv) of P6 mouse calvarium. Representative FACS plots from 10 independent experiments. i, j, FACS for CD146 (i (i), j (i)) and SCA1 (i (ii), j (ii)) in calvarial periosteum of mice at day 15 (top plots) and day 32 (bottom plots). Representative FACS plots from 3 independent experiments.
Extended Data Fig. 5 | Functional characterization of CTSK-mGFP + calvarial suture cells. a, Bright-field images of primary (left; scale bar, 10 µm) and secondary (right) mesenspheres derived from calvarial suture PSCs (top), PP1 (middle) and PP2 (bottom) cells. GFP (green) expression shown in the insets. Representative images from 3 independent experiments. b, Quantification of the percentage of PSC, PP1 and PP2 cells able to form mesenspheres. Tertiary colony formation is significantly reduced in PSCs (**P = 0.0034). PP1 and PP2 cells show significant reduction in both secondary (***P = 0.0002 for PP1 and *P = 0.016 for PP2) and tertiary mesensphere formation (****P = 0.0001 for PP1 and ****P = 0.0001 for PP2). One-way ANOVA, Dunnett's multiple comparison test; mean ± s.d., n = 3 independent experiments. c, Clonal PSC colonies were split for differentiation into osteoblasts (alizarin red staining, left) and adipocytes (oil red O staining, middle; scale bar, 10 µm). Separately, chondrocyte differentiation potential was assayed (alcian blue staining, right; scale bar, 100 µm). Representative images from 3 independent experiments. d, The amount of bone formed by PSCs, PP1, PP2 and non-CTSK MSCs 4 weeks after transplantation into the kidney capsule of secondary hosts was determined by µCT. e, Von Kossa staining (e (i), dotted box in green) displaying bone organoid formation in the kidney capsule by PSCs (top left), non-CTSK MSCs (top right), PP1 (bottom left) and PP2 (bottom right) cells. Scale bar, 50 µm. Safranin O staining (e (ii), dotted box in magenta) indicates an absence of cartilage formation (transplant area shown by dotted yellow line) after transplant of PSCs (left) and PP2 (right) cells. Scale bar, 50 µm. f, In vitro osteogenic differentiation of PSCs (left) and non-CTSK MSCs (right) as determined by Alizarin red staining (red). Images in d-f are representative of 3 independent experiments. g, Heat map generated from quantitative real-time PCR analysis shows differences in gene expression between calvarial suture PSCs and the progenitor populations, PP1 and PP2 cells. h, PSCs were transplanted into a mammary fat pad of primary hosts for 2.5 weeks and then analysed by FACS (i-iii). Colour-coded boxes (green and magenta) indicate parent/daughter gates. i, FACS analysis of PP2 cells after transplantation into the mammary fat pad of primary hosts (i-iii). j, FACS analysis shows poor engraftment and loss of PP1 cells (as detected by GFP expression) when transplanted into the mammary fat pad of primary hosts. k-m, FACS plots demonstrating the in vitro differentiation of PSC (k), PP1 (l), and PP2 cells (m) when cultured for 2 weeks. Magenta boxes indicate parent/daughter gates for each analysed cell population. Plots in h-m represent results from 3 independent experiments.
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Human research participants
Policy information about studies involving human research participants Population characteristics 25 patients undergoing orthopedic procedures underwent periosteum harvest. This group had an age range of 18-35 (median 23) , and were 67% male.
Recruitment
Participants were recruited on an "as available" basis by participating surgeons (Dr. John Healey). Recruitment bias is unlikely to impact this study as no patient comparisons are performed and no analysis of demographic or clinical covariates on cellular properties is performed.
Flow Cytometry Plots
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The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology Sample preparation
Skeletal tissue from postnatal day 7, 15 or 32 mice was subjected to both mechanical and enzymatic digestion. The harvested tissue was minced using razor blades and digested for up to 1 hour with Collagenase P (1mg/ml; Roche, cat 11213857001) + Dispase II (2mg/ml; Roche, cat 04942078001) digestion buffer at 37oC with agitation. Media containing 2% serum was added to the digest and the tubes were centrifuged to pellet cells. The supernatant was removed, and the pellet was resuspended in DNase I (2 units/ml) solution and briefly incubated for 5 mins at 37oC. Media was added to the tube and the digested tissue was re-suspended thoroughly by pipetting and then filtered thorough 70-micron nylon mesh. Tubes were centrifuged and the resulting cell pellet was subjected to FACS. Microdissection of mouse periosteum, calvarial suture and calvarial periosteum was performed under a dissecting microscope and the resulting tissue samples were subjected to the same digestion protocol. For human samples, tissue was treated with Pronase (1mg/ml; Roche, cat 10165921001) for 20 minutes at 37oC under agitation and spun down at 1500 rpm for 10 minutes prior to collagenase treatment as above. Cells were washed twice with ice cold FACS buffer (2% FBS + 1mM EDTA in PBS), incubated with blocking buffer (1:100 dilution; BD bioscience 553142 for mouse and 564765 for human) for 15 mins at 4oC. Primary antibody dilutions were prepared in brilliant stain buffer (BD bioscience 563794). Cells were incubated in the dark for 1 hour on ice with primary antibody solution, washed 2 to 3 times with FACS buffer, and incubated with secondary antibody solution for 20 minutes. Cells were then washed several times and re-suspended in FACS buffer with DAPI (4-6, Diamidino-2-Phenylindole; 1μg/ml; Invitrogen D1306).
Instrument
FACS was performed using a Becton-Dickinson Aria II equipped with 5 lasers (BD bioscience). For single cell RNA sequencing experiment, CTSK-mGFP positive cells isolated from 6-day old mouse femur were sorted by FACS (Bencton -Dickinson Influx, equipped with 6 lasers) and plated into individual wells of a 384 well-plate pre-loaded with unique barcoded RT-primers.
Software
Typically, 1 to 2 million events were recorded for each sample, and the data was analyzed using FlowJo (version 10.1).
Cell population abundance Sorting was performed using a 4-way collection, and was validated to result in >95% purity of the intended population in postsort fractions.
Gating strategy
Beads (eBioscience 01-1111) were used to set initial compensation. Fluorescence minus one (FMO) controls were used for additional compensation and to assess background levels for each stain. Gates were drawn as determined by internal FMO controls to separate positive and negative populations for each cell surface marker. We selected live cells (neagtive for DAPI) and excluded doublets. Mesenchymal cell populations negative for CD45, CD31 and Ter119 cell surface markers were analyzed according to the approach described in Supplementary figure 2d.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
